Eye On A.I.
#249 Brice Challamel: How Moderna is Using AI to Disrupt Modern Healthcare
Apr 20, 2025
Brice Challamel, Head of AI Products and Innovation at Moderna and former Google Cloud executive, discusses how AI is revolutionizing modern healthcare. He explains Moderna's approach to operationalizing AI across its business, treating it as a utility to drive innovation. Listeners learn how AI expedites drug approvals and clinical trials, as well as its role in personalized cancer treatment. Challamel also touches on the company's extensive AI solutions and collaborative efforts with the FDA, showcasing a future where AI and mRNA technology redefine medicine.
49:57
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Moderna views AI as a utility, empowering all employees to enhance innovation and streamline processes across its operations.
- The company is pioneering personalized cancer therapies through mRNA-driven treatments tailored to individual patient profiles.
Deep dives
AI's Role in Drug Design and Approval
Moderna is advancing drug design through AI, emphasizing its importance within the complex clinical trial and regulatory approval processes. With over 50 ongoing clinical trials, the company faces significant challenges in navigating these thorough processes crucial for ensuring patient safety and efficacy. AI is positioned to streamline these efforts, enhancing the efficiency of regulatory submissions and technical development. By enabling faster clinical trial implementation and compliance, AI helps Moderna translate their drug development pipeline into lifesaving treatments more effectively.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
